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Antibiotic resistance is a very current topic health 
concern and represents one of the most important chal-
lenges of the 21st century to human health because, due 
to extensive use over the last decades, antibiotics are 
gradually losing their effectiveness. For example, methi-
cillin resistant Staphylococcus aureus (MRSA) isolated 
since the early 1960s, still represents more than 60% of 
all the S. aureus isolates in US hospitals (NNIS 2004), 
despite recent data demonstrating that the incidence 
of serious infections due to MRSA has decreased since 
2005 in numerous settings (Dantes et al., 2013). At 
the same time the appearance of a further resistance 
against vancomycin (vancomycin resistance Staphylo­
coccus aureus, VRSA) (Sievert et al., 2002) and its pos-
sible transfer by conjugation (de Niederhausern et al., 
2011), could aggravate the situation. Also Enterococcus 
spp., isolated from hospital and food-animal samples, 
has developed resistance against many antibiotics, 
including vancomycin (de Niederhausern et al., 2007). 
Finally, considering the increase of multiresistant 
Gram-negative bacilli (MRGNB) such as Klebsiella 
spp., Escherichia coli and Pseudomonas aeruginosa 
to beta-lactam antibiotics (penicillins, cefalosporins, 
monobactams, carbapenems) (Shaikh et al., 2015), it 
becomes increasingly urgent to experiment different 
antimicrobial treatments. A possible alternative is rep-
resented by photodynamic therapy (PDT), a treatment 
that achieves cytotoxic activity using a combination of 
visible light, a chemical compound photosensitizer 
and oxygen. The antimicrobial PDT was overtaken by 
the discovery of antibiotics, but today could offer new 
therapeutic opportunities for localized infections and 
those that don’t require systemic therapies, especially if 
caused by multidrug-resistant bacteria. Among the sev-
eral advantages of antimicrobial PDT, the most impor-
tant are non-target specificity and the few side effects. 
Furthermore, bacterial inactivation is obtained with an 
action not related to the antibiotic-resistance mecha-
nisms (Jori et al., 2006; Tavares et al., 2010). A remarka-
ble variety of photosensitizing compounds (porphyrins, 
metallo-porphyrins and derivatives), when activated, 
have shown efficacy in the photo-killing of pathogenic 
bacteria regardless of their sensitivity or resistance to 
antibiotics (Lazzeri et al., 2004; Merchat et al., 1996b), 
but their efficacy can significantly change, relatively to 
the microorganism target (Huang et al., 2010). Gener-
ally neutral and anionic photosensitizers exhibit con-
siderable phototoxic activity against Gram-positive and 
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no significant activity against Gram-negative bacteria, 
unless the outer membrane permeability is enhanced, 
prior to irradiation, by treatment with chelating agents 
(Reddi et al., 2002). In contrast, cationic porphyrins, 
under appropriate conditions, promote efficient inacti-
vation of Gram-negative bacteria also, without the need 
for modifying the permeability of the outer membrane 
(Merchat et al., 1996a). During the planning of the PDT 
it must therefore take into account this particular fea-
ture, relative to the photosensitizers employed, as well 
as the operating conditions. It is therefore extremely 
crucial to define a protocol that would allow to obtain 
a reduction of the microbial cells at the same time pre-
venting damage to the host tissues. In view of these 
premises, the present work investigated the antibacte-
rial activity of a cationic porphyrin against two Gram-
positive and two Gram-negative multidrug-resistant 
bacteria employing low concentrations of the photo-
sensitizer, short incubation in the dark and short times 
of exposure to a monochromatic laser light. In a second 
step the Gram-negative bacteria were subjected to the 
same treatment after exposure to EDTA.
The following microorganisms, all from the Amer-
ican Type Culture Collection (Manassas, VA, USA), 
were used: methicillin resistant S. aureus ATCC BAA-
2094 and vancomycin resistant E. faecalis ATCC BAA-
2128 (Gram-positive), multidrug-resistant E. coli ATCC 
BAA-2452 and P. aeruginosa ATCC BAA-2109 (Gram-
negative). The strains were grown at 37°C for 24 h in 
Tryptic Soy broth or Tryptic Soy agar (TSB or TSA, 
Difco Laboratories, Detroit, MI) and were maintained 
at 80°C in the appropriate cultivation broth containing 
20% (v/v) glycerol (Merck, Darmstadt, Germany).
We used a meso substituted tetracationic porphy-
rine (meso-tri(N-methyl-pyridyl), mono(N-tetradecyl-
pyridyl)porphine (C14) (kindly provided by Prof. Jori, 
European Patent Application EP 1 457 113 A1 2004) 
a synthetic compound of the tetrapyrrole series, hav-
ing three positive charges situated in peripheral sub-
stituents of the tetrapyrrolic macrocycle core (alkyl 
chain), and one hydrophobic hydrocarbon chain of 
14 carbon atoms as a peripheral substituent tail. Cell 
irradiation experiments were performed by using 
a diode laser with 635 nm wavelength, output power 
50 mW, 300 nm diameter optical fibers (LAMBDA 
Scien tifica, Vicenza, Italy).
Overnight cultures in TSB of S. aureus ATCC BAA-
2094, E. faecalis ATCC BAA-2128, E. coli ATCC BAA-
2452 and P. aeruginosa ATCC BAA-2109, were centri-
fuged at 10,000 × g for 10 min at 4°C. The supernatant 
was discarded and the cells were harvested, washed 
twice, and resuspended in Phosphate Buffer Saline (PBS, 
pH 6) to give of about l07 CFU/ml. The resultant bacte-
rial suspensions were aseptically distributed in eppen-
dorf tubes and added of suitable volume of porphyrin 
C14 to a final concentration of 5 and 10 µg/ml. The bac-
terial cells were mixed carefully, incubated in the dark 
and room temperature for 60’’, to allow the binding and/
or uptake of the porphyrin, and subjected to irradia-
tion for 30’’and 60’’ using a monochromatic light laser. 
The laser fibre was placed in the bottom of eppendorf 
tube and a spiral movement was manually performed 
to ensure uniform diffusion of the light. Afterward 
tenfold dilutions of each suspension were seeded on 
TSA and, following a 24 h incubation at 37°C, viable 
counts (CFU/ml) were determined. Two controls were 
performed (only laser light irradiation and porphyrin 
without any irradiation).
In a second step of the study, in consideration of 
the low susceptibility of Gram-negative bacteria to the 
PD treatment, suspensions of E. coli and P. aeruginosa 
were processed with EDTA (3 mM) for 60’’ before the 
treatment with 10 µg/ml of porphyrin and 60’’ of laser 
light irradiation.
The experiments were repeated three times, the data 
(log bacterial count) were averaged and standard devia-
tion was calculated. Bacterial reduction in percentage 
was determined using the following formula:
R% = [(B–A) / B] × 100
R: percentage reduction of the microbial cells;
A: sample microbial suspension (CFU/ml);
B: control microbial suspension (CFU/ml)
The decline rates of S. aureus, E. faecalis, E. coli and 
P. aeruginosa were analyzed using a t-test for paired 
data. A statistical probability equal to or less than 0.05 
was considered significant.
The antibacterial activity of the photo-activated por-
phyrin against S. aureus ATCC BAA-2094, E. faeca lis 
ATCC BAA-2128, E. coli ATCC BAA-2452 and P. aeru­
ginosa ATCC BAA-2109 is summarized in Table I. The 
Gram-positive bacteria showed a remarkable suscep-
ti bility to photodynamic treatment. With the high-
est parameters employed (10 µg/ml of porphyrin, 
60’’ of dark incubation time and 60’’ of irradiation) 
we obtained a bactericidal activity with viable counts 
decrease of 3.7 and 4.4 log CFU/ml for S. aureus and 
E. faecalis (99.98% and 99.996% reduction, respectively) 
(p < 0.01 compared to controls). Even using the lower 
parameters (5 µg/ml of porphyrin, 60’’ of dark incuba-
tion time and 30’’ of irradiation) we obtained a signifi-
cant reduction (99.29% and 99.52%, respectively). In 
the same experimental conditions, and also employing 
the highest treatment parameters, the Gram-negative 
bacteria E. coli and P. aeruginosa showed a lower sus-
ceptibility (decrease respectively of 40.8% and 73%, 
p > 0.05). This outcome is probably due to the low outer 
membrane permeability that affects the uptake of the 
porphyrin (Reddi et al., 2002). Our results against the 
Gram-negative bacteria, are partially in disagreement 
with the studies of Merchat et al. (1996a) who found 
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that cationic porphyrins like C14 show bactericidal 
activity without the addition of chelating agents. This 
discrepancy could be due to the feature of our experi-
mental design, carried out in mild operating condi-
tions: low dark incubation time with photosensitizer 
(60’’) and low laser light irradiation time (30’’–60’’). In 
the second step of the study, the addition of EDTA to 
the cell suspensions before PD treatment has produced 
a decrease of about 2,7 and 3,5 log CFU/ml in E. coli and 
P. aeruginosa viable counts (Table II), with a reduction 
of 99.83 and 99.97 %, respectively (p < 0,01). Relatively 
to controls, the only exposure to laser light does not 
caused significant effects on bacterial viability, while 
the not photo-activated porphyrin at the highest con-
centration (10 µg/ml) produced a reduction of 1.5 and 
2.3 log CFU/ml for S. aureus and E. faecalis, and lower 
than 1 log for E. coli and P. aeruginosa. This antibacterial 
activity observed without laser light irradiation could 
be ascribed to the presence of the long hydrocarbon tail, 
which can interact with hydrophobic areas in the cell 
membrane, inducing a marked alteration of the native 
three-dimensional architecture and impairing specific 
metabolic processes (Maraggia, 2006).
According to our results if the experimental design 
employed in this study is proved effective in bacterial 
photo-inactivation also in vivo, the antimicrobial PDT 
could be suitably used for less invasive treatments that 
do not require systemic antibiotic therapies. Porphyrin 
C14 or a similar photosensitizer could be employed for 
the treatment of localized infections, chronic wounds, 
oral candidiasis and in the dental field for cariogenic 
and periodontal diseases (Jori et al., 2006) in particu-
lar when caused by multidrug-resistant Gram-positive 
and Gram-negative bacteria. The low sensitivity of 
Gram-negative bacteria observed in our study can be 
overcome by employing a combination of porphyrin 
and EDTA. Using this association we achieved a reduc-
tion in viable counts such as those observed for the 
Gram-positive bacteria. The advantage of PDT, as 
appears from our data, is that the bactericidal activity 
is obtained employing low dark incubation time with 
photosensitizer, low dosages of porphyrin and very 
short irradiation times; as previously referred by Dai 
et al. (2009), if irradiation is performed at short inter-
vals after photosensitizer application (minutes), the 
PDT damage to host tissue will be minimized. Mem-
branes and cell wall components are the main targets of 
PDT and the photosensitizers do not need to enter the 
cell, but the adhesion to these structures is sufficient for 
bacterial inactivation. In this way the microorganisms 
don’t have the possibility to develop resistance through 
the known mechanisms. Unlike antibiotics, repeated 
S. aureus 6.96* ± 0.07 6.95 ± 0.08 5.98 ± 0.04 5.53 ± 0.04 4.87 ± 0.01 4.28 ± 0.03 3.87 ± 0.01 3.25 ± 0.02
7.02 ± 0.04* 12.5%** 13.46% 90.76% 96.73% 99.29% 99.82% 99.93% 99.98%
E. faecalis 7.02 ± 0.08 7.11 ± 0.07 5.14 ± 0.02 4.95 ± 0.07 4.90 ± 0.03 4.56 ± 0.09 3.17 ± 0.05 2.83 ± 0.06
7.22 ± 0.05 37.12% 22.15% 91.79% 99.46% 99.52% 99.78% 99.991% 99.996%
E. coli 7.18 ± 0.04 7.06 ± 0.06 7.12 ± 0.04 7.11 ± 0.06 7.10 ± 0.08 7.08 ± 0.01 7.02 ± 0.03 6.99 ± 0.05
7.21 ± 0.02 8.7% 8.7% 20.12% 20.7% 21.95% 26.2% 35.5% 40.8%
P. aeruginosa 5.73 ± 0.09 5.74 ± 0.03 5.63 ± 0.03 5.56 ± 0.08 5.61 ± 0.05 5.60 ± 0.02 5.54 ± 0.07 5.51 ± 0.02
6.08 ± 0.06 55% 54% 64.4% 69.7% 65.67% 66.6% 70.83% 73%
Table I 
Antibacterial activity of photo-activated porphyrin against S. aureus, E. faecalis, E. coli and P. aeruginosa after 1 min dark incubation
* Log CFU/ml, ** % reduction, Por = porphyrin







E. coli 7.6* ± 0.07 7.58 ± 0.04 7.54 ± 0.08 7.28 ± 0.02 7.34 ± 0.05 4.92 ± 0.02
7.70* ± 0.04 18%** 24% 30% 62% 56% 99.83%
P. aeruginosa 7.40 ± 0.03 7.34 ± 0.08 7.34 ± 0.09 7.32 ± 0.05 5.34 ± 0.04 4.38 ± 0.07
7.89 ± 0.04 67.53% 71.81% 71.81% 72.98% 99.72% 99.97%
Table II
Antibacterial activity of photo-activated porphyrin against E. coli and P. aeruginosa
(60’’ dark incubation with 10 µg/ml of porphyrin) after EDTA addition
* log CFU/ml,  ** % reduction, Por = porphyrin
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photodynamic treatments do not seem to induce the 
selection of resistant bacteria, as singlet oxygen and 
free radicals interact with numerous cell structures and 
different metabolic pathways of the microorganisms 
(Wainwright and Crossley, 2004). Consequently, this 
therapeutic approach may be a viable alternative to the 
use of antibiotics in particular against infections due to 
multidrug-resistant bacteria, opening new prospects for 
the use of photosensitized processes in the medical field.
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